Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$155,794,886
+$7,668,501 QoQ
Shares Held
430,230
+2.2% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#105
of 3,149 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 88%
None 12%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. AMGN ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
This page
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in AMGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,794,886 | 430,230 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $148,126,385 | 420,993 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $221,247,156 | 675,956 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $346,082,177 | 1,226,372 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $100,573,116 | 360,206 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $64,131,630 | 205,847 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $139,262,296 | 534,309 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $249,853,555 | 775,437 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $213,971,382 | 684,818 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $231,929,489 | 815,734 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $231,077,002 | 802,295 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $211,471,922 | 786,843 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $139,185,001 | 626,903 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $65,205,050 | 269,721 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $62,176,078 | 236,735 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $32,932,066 | 146,105 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $39,781,982 | 163,510 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $44,004,709 | 181,973 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $23,545,585 | 104,661 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||